Integrase inhibitor best for HIV patients with cancerA third of deaths in HIV patients now due to malignancy: Texas study Erivedge: first targeted therapy for basal cell carcinomaNew drug indicated in adults for the treatment of histologically confirmed metastatic basal cell carcinoma or locally advanced basal cell carcinoma that is inappropriate for surgery or radiotherapy CCBs linked with breast cancer Night shifts a breast cancer risk New cancer drugs release the brakes on the immune system Early trials of immunotherapy mark ‘new chapter’ in oncology Fitness in midlife predicts cancer incidence and survival in men Even a small improvement in exercise capacity makes a difference Radiation safe in lymph node-positive breast cancer Recurrence rates similar, swelling less common than with surgery Guidelines for prevention of acute antineoplastic-induced nausea and vomiting in children Pediatric Oncology Group of Ontario spearheads development of guidelines for the prevention of acute antineoplastic-induced nausea and vomiting in children. CUA: Testosterone level should guide androgen deprivation therapy Analysis shows importance of reaching low values CUA: Prostate inflammation cuts cancer risk Finding has implications for biopsy followup First Previous 42 43 44 45 46 Next Last
